S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
15 A.I. Trading Opportunities a Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Central Bank: “Final stage” beginning now (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
15 A.I. Trading Opportunities a Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Central Bank: “Final stage” beginning now (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
15 A.I. Trading Opportunities a Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Central Bank: “Final stage” beginning now (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
15 A.I. Trading Opportunities a Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Central Bank: “Final stage” beginning now (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed

Penumbra (PEN) Stock Forecast, Price & News

$306.50
+1.60 (+0.52%)
(As of 05/26/2023 ET)
Compare
Today's Range
$303.00
$308.71
50-Day Range
$266.17
$320.46
52-Week Range
$114.86
$324.38
Volume
254,268 shs
Average Volume
430,050 shs
Market Capitalization
$11.72 billion
P/E Ratio
1,915.74
Dividend Yield
N/A
Price Target
$296.33

Penumbra MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.92 Rating Score
Upside/​Downside
3.3% Downside
$296.33 Price Target
Short Interest
Healthy
8.94% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.28
Upright™ Environmental Score
News Sentiment
0.44mentions of Penumbra in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$7.33 M Sold Last Quarter
Proj. Earnings Growth
64.10%
From $1.56 to $2.56 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars

Medical Sector

628th out of 1,012 stocks

Surgical & Medical Instruments Industry

67th out of 105 stocks


PEN stock logo

About Penumbra (NYSE:PEN) Stock

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

PEN Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
10 Analysts Have This to Say About Penumbra
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Penumbra (NYSE:PEN) Coverage Initiated at StockNews.com
Penumbra, Inc. (NYSE:PEN) CEO Sells $3,078,814.32 in Stock
2030, Guiding Catheters Market Research
Should You Invest in Penumbra (PEN)?
Penumbra's (PEN) Maintains Rating Reaffirmed at 58.com
See More Headlines
Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

PEN Company Calendar

Last Earnings
5/02/2023
Today
5/28/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Employees
3,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$296.33
High Stock Price Forecast
$350.00
Low Stock Price Forecast
$185.00
Forecasted Upside/Downside
-3.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
12 Analysts

Profitability

Net Income
$-2,000,000.00
Pretax Margin
1.99%

Debt

Sales & Book Value

Annual Sales
$847.13 million
Cash Flow
$0.81 per share
Book Value
$26.78 per share

Miscellaneous

Free Float
36,149,000
Market Cap
$11.72 billion
Optionable
Optionable
Beta
0.54

Key Executives

  • Adam ElsesserAdam Elsesser
    Chairman, President & Chief Executive Officer
  • Ben Sorci
    Executive Vice President-Operations
  • Maggie S. Yuen
    Chief Financial Officer
  • Pankaj Tiwari
    Chief Information Officer & Executive VP
  • Corey L. Teigen
    Chief Scientific Officer













PEN Stock - Frequently Asked Questions

Should I buy or sell Penumbra stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PEN shares.
View PEN analyst ratings
or view top-rated stocks.

What is Penumbra's stock price forecast for 2023?

12 equities research analysts have issued 1 year target prices for Penumbra's shares. Their PEN share price forecasts range from $185.00 to $350.00. On average, they anticipate the company's stock price to reach $296.33 in the next year. This suggests that the stock has a possible downside of 3.3%.
View analysts price targets for PEN
or view top-rated stocks among Wall Street analysts.

How have PEN shares performed in 2023?

Penumbra's stock was trading at $222.46 at the start of the year. Since then, PEN stock has increased by 37.8% and is now trading at $306.50.
View the best growth stocks for 2023 here
.

When is Penumbra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our PEN earnings forecast
.

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) announced its quarterly earnings data on Tuesday, May, 2nd. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.11 by $0.12. The firm earned $241.40 million during the quarter, compared to analysts' expectations of $229.70 million. Penumbra had a net margin of 0.73% and a trailing twelve-month return on equity of 1.58%. Penumbra's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.01) earnings per share.

What guidance has Penumbra issued on next quarter's earnings?

Penumbra issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.04 billion-$1.06 billion, compared to the consensus revenue estimate of $1.01 billion.

What is Adam Elsesser's approval rating as Penumbra's CEO?

57 employees have rated Penumbra Chief Executive Officer Adam Elsesser on Glassdoor.com. Adam Elsesser has an approval rating of 88% among the company's employees.

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), AbbVie (ABBV), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Netflix (NFLX), UnitedHealth Group (UNH), Boeing (BA) and DexCom (DXCM).

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

Who are Penumbra's major shareholders?

Penumbra's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (14.69%), BlackRock Inc. (11.58%), Price T Rowe Associates Inc. MD (5.71%), State Street Corp (2.73%), Clearbridge Investments LLC (2.48%) and William Blair Investment Management LLC (2.46%). Insiders that own company stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Surbhi Sarna and Thomas Wilder.
View institutional ownership trends
.

How do I buy shares of Penumbra?

Shares of PEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $306.50.

How much money does Penumbra make?

Penumbra (NYSE:PEN) has a market capitalization of $11.72 billion and generates $847.13 million in revenue each year. The company earns $-2,000,000.00 in net income (profit) each year or $0.16 on an earnings per share basis.

How many employees does Penumbra have?

The company employs 3,900 workers across the globe.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The official website for the company is www.penumbrainc.com. The company can be reached via phone at (510) 748-3200, via email at investors@penumbrainc.com, or via fax at 510-748-3232.

This page (NYSE:PEN) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -